An evidence-based review of the surgical treatment of gastric adenocarcinoma. J Gastrointest Surg 2011 May;15(5):730-41
Date
03/15/2011Pubmed ID
21399886DOI
10.1007/s11605-011-1477-yScopus ID
2-s2.0-79955466902 (requires institutional sign-in at Scopus site) 9 CitationsAbstract
The management of gastric adenocarcinoma continues to evolve. Chemotherapy is being increasingly used in both the neoadjuvant and adjuvant setting. Surgical resection of the stomach and regional lymph nodes remains the mainstay of potentially curative therapy, but significant regional differences persist in the surgical management. This review provides an update on the current literature regarding the preoperative evaluation and staging, extent of gastric resection, extent of lymph node resection, and adjuvant therapy for patients with gastric adenocarcinoma.
Author List
Maduekwe UN, Yoon SSAuthor
Ugwuji N. Maduekwe MD Associate Dean, Associate Professor in the Surgery department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdenocarcinomaGastrectomy
Humans
Lymph Node Excision
Lymphatic Metastasis
Neoplasm Staging
Stomach Neoplasms









